Core Insights - Over a quarter of American adults with diabetes used GLP-1 injection drugs last year, indicating a significant adoption of these medications for managing type 2 diabetes and weight loss [4] - The most common age group using these drugs is 50 to 64 years old, with a usage rate of 33.3%, reflecting a higher disease burden in this demographic [4] - The high cost of GLP-1 drugs, approximately $1,000 per month, has drawn criticism despite their effectiveness [6] Usage Statistics - Approximately 31% of insulin users also use GLP-1 drugs, while about 28% of oral hypoglycemic drug users do the same, suggesting GLP-1 therapy is increasingly integrated into combination treatment plans [6] - Among different ethnic groups, Hispanic diabetic adults have the highest usage rate of GLP-1 drugs at 31.3%, followed by non-Hispanic Black at 26.5% and non-Hispanic White at 26.2%. Non-Hispanic Asian adults have the lowest usage rate at 12.1% [6] Drug Mechanism - GLP-1 drugs mimic the action of hormones that regulate blood sugar levels, delay digestion, and prolong feelings of fullness, contributing to blood sugar control and weight loss [6][15]
速递|风靡全球!去年四分之一的美国糖尿病患者使用了GLP-1药物